title: Second-line treatment for advanced thyroid cancer: an indication in need of randomized clinical trials.
authors.affiliation: Department of Medicine (A.B.C., M.S.B.) and Department of Otorhinolaryngology, Head and Neck Surgery (M.S.B.), Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania 19104.
authors.forename: Aaron B
authors.initials: AB
authors.lastname: Cohen
authors.forename: Marcia S
authors.initials: MS
authors.lastname: Brose
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D018450:Disease Progression; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D017211:Treatment Failure
chemical_list: D007457:Iodine Radioisotopes